| Date | Name | Description | Press Release |
|---|
| December 18, 2020 | Osimertinib | FDA approves osimertinib as adjuvant therapy for non-small cell lung cancer with EGFR mutations | More Info |
| December 18, 2020 | relugolix | FDA approves relugolix for advanced prostate cancer | More Info |
| December 18, 2020 | Selinexor | FDA approves selinexor for refractory or relapsed multiple myeloma | More Info |
| December 16, 2020 | margetuximab-cmkb | FDA approves margetuximab for metastatic HER2-positive breast cancer | More Info |
| December 1, 2020 | Gallium 68 PSMA-11 | FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer | More Info |
| December 1, 2020 | pralsetinib | FDA approves pralsetinib for RET-altered thyroid cancers | More Info |
| November 25, 2020 | naxitamab | FDA grants accelerated approval to naxitamab for high-risk neuroblastoma in bone or bone marrow | More Info |
| November 23, 2020 | lumasiran | FDA Approves First Drug to Treat Rare Metabolic Disorder | More Info |
| November 20, 2020 | lonafarnib | FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies | More Info |
| November 13, 2020 | pembrolizumab | FDA grants accelerated approval to pembrolizumab for locally recurrent unresectable or metastatic triple negative breast cancer | More Info |
| October 22, 2020 | remdesivir | FDA Approves First Treatment for COVID-19 | More Info |
| October 16, 2020 | venetoclax | FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukemia | More Info |
| October 14, 2020 | atoltivimab, maftivimab, and odesivimab-ebgn | FDA Approves First Treatment for Ebola Virus | More Info |
| October 14, 2020 | pembrolizumab | FDA extends approval of pembrolizumab for classical Hodgkin lymphoma | More Info |
| October 2, 2020 | nivolumab; ipilimumab | FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma | More Info |
| September 4, 2020 | pralsetinib | FDA approves pralsetinib for lung cancer with RET gene fusions | More Info |
| September 1, 2020 | onureg | FDA approves Onureg (azacitidine tablets) for acute myeloid leukemia | More Info |
| August 20, 2020 | carfilzomib and daratumumab | FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma | More Info |
| August 17, 2020 | satralizumab-mwge | FDA Approves Treatment for Rare Disease Affecting Optic Nerves, Spinal Cord | More Info |
| August 12, 2020 | viltolarsen | FDA Approves Targeted Treatment for Rare Duchenne Muscular Dystrophy Mutation | More Info |
| August 7, 2020 | oliceridine | FDA Approves New Opioid for Intravenous Use in Hospitals, Other Controlled Clinical Settings | More Info |
| August 7, 2020 | risdiplam | FDA Approves Oral Treatment for Spinal Muscular Atrophy | More Info |
| August 5, 2020 | Belantamab Mafodotin-blmf | FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma | More Info |
| July 31, 2020 | Tafasitamab-cxix | FDA grants accelerated approval to tafasitamab-cxix for diffuse large B-cell lymphoma | More Info |
| July 30, 2020 | Atezolizumabn | FDA approves atezolizumab for BRAF V600 unresectable or metastatic melanoma | More Info |
| July 24, 2020 | Brexucabtagene Autoleucel | FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL | More Info |
| July 2, 2020 | Fostemsavir | FDA Approves New HIV Treatment for Patients With Limited Treatment Options | More Info |
| June 22, 2020 | Selinexor | FDA Grants Accelerated Approval to Selinexor for Relapsed/Refractory Diffuse Large B-Cell Lymphoma | More Info |
June 18, 2020 | Tazemetostat | FDA granted accelerated approval to tazemetostat for follicular lymphoma | More Info |
| June 16, 2020 | Gemtuzumab Ozogamicin | FDA approves gemtuzumab ozogamicin for CD33-positive AML in pediatric patients | More Info |
| June 16, 2020 | Pembrolizumab | FDA approves pembrolizumab for adults and children with TMB-H solid tumors | More Info |
| June 15, 2020 | Lurbinectedin | FDA approves lurbinectedin to treat metastatic small cell lung cancer | More Info |
| June 11, 2020 | Inebilizumab-cdon | FDA Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord | More Info |
| May 26, 2020 | Artesunate | FDA Approves Only Drug in U.S. to Treat Severe Malaria | More Info |
| May 15, 2020 | Ripretinib | FDA Approves First Drug for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors | More Info |
| May 8, 2020 | Selpercatinib | FDA Approves First Therapy for Patients with Lung and Thyroid Cancers with a Certain Genetic Mutation or Fusion | More Info |
| May 6, 2020 | Capmatinib | FDA Approves First Targeted Therapy to Treat Aggressive Form of Lung Cancer | More Info |